Suppr超能文献

补体因子 B 可裂解键的可及性通过因子 B 与 C3b 蛋白的结合得到促进。

Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.

机构信息

Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110.

Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

J Biol Chem. 2011 Oct 14;286(41):35725-35732. doi: 10.1074/jbc.M111.263418. Epub 2011 Aug 23.

Abstract

Factor B is a zymogen that carries the catalytic site of the complement alternative pathway C3 convertase. During convertase assembly, factor B associates with C3b and Mg(2+) forming a pro-convertase C3bB(Mg(2+)) that is cleaved at a single factor B site by factor D. In free factor B, a pair of salt bridges binds the Arg(234) side chain to Glu(446) and to Glu(207), forming a double latch structure that sequesters the scissile bond (between Arg(234) and Lys(235)) and minimizes its unproductive cleavage. It is unknown how the double latch is released in the pro-convertase. Here, we introduce single amino acid substitutions into factor B that preclude one or both of the Arg(234) salt bridges, and we examine their impact on several different pro-convertase complexes. Our results indicate that loss of the Arg(234)-Glu(446) salt bridge partially stabilizes C3bB(Mg(2+)). Loss of the Arg(234)-Glu(207) salt bridge has lesser effects. We propose that when factor B first associates with C3b, it bears two intact Arg(234) salt bridges. The complex rapidly dissociates unless the Arg(234)-Glu(446) salt bridge is released whereupon conformational changes occur that activate the metal ion-dependent adhesion site and partially stabilize the complex. The remaining salt bridge is then released, exposing the scissile bond and permitting factor D cleavage.

摘要

因子 B 是一种酶原,它携带补体替代途径 C3 转化酶的催化位点。在转化酶组装过程中,因子 B 与 C3b 和 Mg(2+)结合形成前转化酶 C3bB(Mg(2+),它在因子 D 的作用下在因子 B 的单个位点被切割。在游离因子 B 中,一对盐桥将 Arg(234)侧链结合到 Glu(446)和 Glu(207)上,形成双闩锁结构,将裂解键(Arg(234)和 Lys(235)之间)隔离并最小化其非生产性切割。尚不清楚双闩锁在前转化酶中是如何释放的。在这里,我们引入了因子 B 中的单个氨基酸取代,这些取代排除了一个或两个 Arg(234)盐桥,并研究了它们对几种不同的前转化酶复合物的影响。我们的结果表明,Arg(234)-Glu(446)盐桥的缺失部分稳定了 C3bB(Mg(2+)。Arg(234)-Glu(207)盐桥的缺失则产生较小的影响。我们提出,当因子 B 首次与 C3b 结合时,它具有两个完整的 Arg(234)盐桥。除非 Arg(234)-Glu(446)盐桥释放,否则复合物会迅速解离,此时会发生构象变化,激活金属离子依赖性粘附位点并部分稳定复合物。然后释放剩余的盐桥,暴露裂解键并允许因子 D 切割。

相似文献

引用本文的文献

1
Factor B as a therapeutic target for the treatment of complement-mediated diseases.作为补体介导疾病治疗靶点的B因子
Front Immunol. 2025 Feb 14;16:1537974. doi: 10.3389/fimmu.2025.1537974. eCollection 2025.
6
Low-molecular weight inhibitors of the alternative complement pathway.替代补体途径的低分子量抑制剂。
Immunol Rev. 2023 Jan;313(1):339-357. doi: 10.1111/imr.13143. Epub 2022 Oct 11.

本文引用的文献

2
9
The spectrum of complement alternative pathway-mediated diseases.补体替代途径介导的疾病谱。
Immunol Rev. 2008 Jun;223:300-16. doi: 10.1111/j.1600-065X.2008.00641.x.
10
Complement-targeted therapeutics.补体靶向疗法。
Nat Biotechnol. 2007 Nov;25(11):1265-75. doi: 10.1038/nbt1342.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验